第39回日本分子生物学会シンポジウム [3AS13](2016.12.2 横浜)

NOVEL STRATEGIES TOWARD UNDERSTANDING MECHANISMS THAT LEAD TO REFRACTORY CANCER

Organizers:

Satoshi Inoue (Saitama Med Univ/Tokyo Metro Inst of Gerontol)

Koji Okamoto (Natl Cancer Ctr Res Inst)

[3AS13-1]

Identification of stemness-maintaining factors in breast cancer stem cells

Takahiko Maruyama (IMS, Univ of Tokyo)


[3AS13-2]

In vitro cultivation and characterization of cancer stem cells derived from refractory cancer in spheroid culture

Koji Okamoto (Natl Cancer Ctr Res Inst)


[3AS13-3]

Identification of targets of tumor suppressor microRNA-341 using a reporter library system

Yoshiaki Ito (Dept Syst BioMed,Tokyo Med Dent Univ)


[3AS13-4]

Co-factor and epigenomic control of hormone sensitive and refractory human cancers

Debabrata Chakravarti (Northwestern Univ, Chicago,USA)


[3AS13-5]

Functional shRNA library screening and sequencing-based identification of coding and non-coding RNAs that associate with the biology of hormone refractory cancers

Kuniko Horie (Res Ctr for Genomic Med, Saitama Med Univ)


[3AS13-6]

Toward tailoring colorectal cancer chemotherapeutics via patient derived organoids

Masayuki Fujii (Dept of Int Med, Dev of Gastrorenterol, Keio Univ Sch of Med)


[3AS13-7]

Reconstructing tumor microenvironment in cancer organoids

Ryo Okuda (Dept of Regenerative Med, Yokohama City Univ, Grad Sch Med)


[3AS13-8]

Dependence on the mitochondrial MTHFD2-mediated purine synthetic pathway in lung cancer

Noriko Gotoh (Div of Cancer Cell Biol, Cancer Res Inst, Kanazawa Univ)